Chinese Peptide Company
Generic APIs

Generic Peptides

In addition, CPC specializes in the production of generic peptides on an industrial scale, following the CGMP's (Current Good Manufacturing Practices). Our expertise allows us to manufacture a range of high-quality generic peptides at a commercial scale. With stringent quality control measures in place, we ensure consistent and reliable production of generic peptides that meet regulatory standards.    

Our Generic API Portfolio:


 Disease Area

API

Indication

DMF Status

Tumour

Leuprorelin Acetate

Prostate & Breast Cancer; 

Endometriosis; Uterine Leiomyomata; 

Precocious Puberty

MFDS: 20200625-210-J-661              

NMPA: Y20190007496(A)

TFDA: 110DMF050097

Triptorelin Acetate

Prostate & Breast Cancer; 

Endometriosis; Uterine Leiomyomata; 

Assisted Reproduction

NMPA: Y20170001090(A)

Goserelin Acetate

Suppress production of the sex hormones

NMPA: Y20230000413

Triptorelin Pamoate

Endometriosis; Uterine Fibroids; 

Premature Puberty; Prostate Cancer; ART.

NMPA:2024 Q2

Procreation

Cetrorelix Acetate

In Vitro Fertilization (IVF)

NMPA: Y20190001147(A) FDA: 034884

Diabetes

Exenatide Acetate

Exenatide is an injectable diabetes medicine 

that helps control blood sugar levels. 

This medication helps pancreas produce 

insulin more efficiently

NMPA: 2015/12                           

NMPA: Y20170001378

Semaglutide

Type ll diabetes

DMF: 2024 Q1

NMPA: 2024 Q1

Tirzepatide

Type ll diabetes

Early R&D

Gastrointestinal

Terlipressin Acetate

An analogue of vasopressin, prescribed for 

bleeding esophageal varices, septic shock, 

hepatorenal syndrome and in management of 

low blood pressure

NMPA:Y20200000281(A)

CEP : 2020-111 

ASMF: The Nethelands (03883)

ASMF: Germany (4388)

EDQM: R0-CEP 2020-111

Linaclotide

lrritable Bowel Syndrome with Constipation (IBS-C):

Chronic Idiopathic Constipation (CIC)

NMPA:Y20210000906

Teduglutide

A prescription medicine for adults with Short Bowel Syndrome 

who need additional nutrition or fluids fromIV feeding

DMF:2024 Q4

Immunology

Difelikefalin

Treatment of moderate-to-severe pruritus associated with 

chronic kidney disease(CKD-aP; uremic pruritus) 

in adults undergoing hemodialysis

 NMPA:2025 Q1





Get In Touch With CPC
Get In Touch With CPC

Please submit a detailed description of your request. We will provide you with professional services to meet your research requests. You can also send emails directly to sales@chinesepeptide.com for inquiries.